Vivendal Comp 160 mg/25 mg Filmdragerad tablett

Maa: Ruotsi

Kieli: ruotsi

Lähde: Läkemedelsverket (Medical Products Agency)

Osta se nyt

Pakkausseloste Pakkausseloste (PIL)
22-04-2018
Valmisteyhteenveto Valmisteyhteenveto (SPC)
22-04-2018

Aktiivinen ainesosa:

hydroklortiazid; valsartan

Saatavilla:

Sandoz A/S

ATC-koodi:

C09DA03

INN (Kansainvälinen yleisnimi):

hydrochlorothiazide; valsartan

Annos:

160 mg/25 mg

Lääkemuoto:

Filmdragerad tablett

Koostumus:

valsartan 160 mg Aktiv substans; hydroklortiazid 25 mg Aktiv substans

luokka:

Apotek

Prescription tyyppi:

Receptbelagt

Terapeuttinen alue:

Valsartan och diuretika

Tuoteyhteenveto:

Förpacknings: Blister, 7 tabletter (plast/Al); Blister, 7 tabletter (Al); Blister, 10 tabletter (Al); Blister, 14 tabletter (Al); Blister, 15 tabletter (Al); Blister, 20 tabletter (Al); Blister, 28 tabletter (Al); Blister, 30 tabletter (Al); Blister, 50 tabletter (Al); Blister, 56 tabletter (Al); Blister, 60 tabletter (Al); Blister, 84 tabletter (Al); Blister, 90 tabletter (Al); Blister, 98 tabletter (Al); Blister, 100 tabletter (Al); Blister, 280 tabletter (Al); Blister, 10 tabletter (plast/Al); Blister, 14 tabletter (plast/Al); Blister, 15 tabletter (plast/Al); Blister, 20 tabletter (plast/Al); Blister, 28 tabletter (plast/Al); Blister, 30 tabletter (plast/Al); Blister, 50 tabletter (plast/Al); Blister, 56 tabletter (plast/Al); Blister, 60 tabletter (plast/Al); Blister, 84 tabletter (plast/Al); Blister, 90 tabletter (plast/Al); Blister, 98 tabletter (plast/Al); Blister, 100 tabletter (plast/Al); Blister, 280 tabletter (plast/Al); Blister, 50 x 1 tabletter, endos (Al); Blister, 50 x 1 tabletter, endos (plast/Al)

Valtuutuksen tilan:

Godkänd

Valtuutus päivämäärä:

2011-04-15

Pakkausseloste

                                PACKAGE LEAFLET: INFORMATION FOR THE USER
Vivendal Comp 80 mg /12.5 mg film-coated tablets
Vivendal Comp 160 mg /12.5 mg film-coated tablets
Vivendal Comp 160 mg /25 mg film-coated tablets
Vivendal Comp 320 mg /12.5 mg film-coated tablets
Vivendal Comp 320 mg /25 mg film-coated tablets
Valsartan/hydrochlorothiazide
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Vivendal Comp is and what it is used for
2.
What you need to know before you take Vivendal Comp
3.
How to take Vivendal Comp
4.
Possible side effects
5.
How to store Vivendal Comp
6.
Contents of the pack and other information
1.
WHAT VIVENDAL COMP IS AND WHAT IT IS USED FOR
Vivendal Comp film-coated tablets contain two active substances called
valsartan and
hydrochlorothiazide. Both of these substances help to control high
blood pressure (hypertension).

VALSARTAN belongs to a class of medicines known as “angiotensin II
receptor antagonists”,
which help to control high blood pressure. Angiotensin II is a
substance in the body that
causes vessels to tighten, thus causing your blood pressure to
increase. Valsartan works by
blocking the effect of angiotensin II. As a result, blood vessels
relax and blood pressure is
lowered.

HYDROCHLOROTHIAZIDE belongs to a group of medicines called thiazide
diuretics (also
known as “water tablets”). Hydrochlorothiazide increases urine
output, which also lowers
blood pressure.
Vivendal Comp is used to treat high blood pressure which is not
adequately controlled by a single
substance a
                                
                                Lue koko asiakirja
                                
                            

Valmisteyhteenveto

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Lue koko asiakirja
                                
                            

Asiakirjat muilla kielillä

Pakkausseloste Pakkausseloste englanti 18-03-2022
Valmisteyhteenveto Valmisteyhteenveto englanti 16-01-2019
Julkisesta arviointikertomuksesta Julkisesta arviointikertomuksesta englanti 21-02-2013